SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-13-002094
Filing Date
2013-04-30
Accepted
2013-04-30 08:26:38
Documents
3
Period of Report
2013-04-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k043013_yewbiopharm.htm 8-K 22758
2 ENGAGEMENT AGREEMENT DATED APRIL 30, 2013 BETWEEN YEW BIO-PHARM GROUP, INC. AND f8k043013ex10i_yewbiopharm.htm EX-10.1 40800
3 ex10i.jpg GRAPHIC 11215
  Complete submission text file 0001213900-13-002094.txt   80222
Mailing Address 294 POWERBILT AVENUE LAS VEGAS NV 89148
Business Address 294 POWERBILT AVENUE LAS VEGAS NV 89148 86-0451-82292379
Yew Bio-Pharm Group, Inc. (Filer) CIK: 0001548240 (see all company filings)

IRS No.: 261579105 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54701 | Film No.: 13794483
SIC: 0100 Agricultural Production-Crops